Product information and disease descriptionPlace of product in therapyDisease description
Long-term morbidity
5 evidence topics · 5 sources
Insulinoma: long-term morbidity compared with matched controls
“The long-term incidence of atrial fibrillation (rate ratio (RR): 2.07 (95% CI: 1.02–4.22)), intestinal obstruction (18.65 (2.09–166.86)), and possibly breast (4.46 (1.29–15.39) and kidney cancers (RR not applicable) was increased among insulinoma patients vs controls, P < 0.05 for all comparisons.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Endocrine disorders and pancreatic diseases were more frequent in the patients during the first year after insulinoma diagnosis, but not later on.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The incidence of dementia or all mental and behavioural disorders did not significantly differ between the patients and the controls” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Insulinoma: late surgical complications
“Most cases of pancreatitis occurred as early postoperative complications, with a rate of 10% in the surgically treated patients, as described previously” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Intestinal obstruction occurred in 5% of the surgically treated patients, likely as a late postoperative complication of insulinoma surgery.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Insulinoma: residual hypoglycemia and post-treatment diabetes in a Japanese nationwide survey
“Post‐surgery residual hypoglycemia was found in eight patients: one had benign, five had malignant, and two had unknown histology.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“By contrast, post‐treatment diabetes mellitus was more prevalent and found in 25 (15.8%) patients who underwent pancreatectomy: 3.8% of those who had tumor enucleation, 21.3% of body and/or tail resection, 26.3% of pancreatoduodenectomy, and 100% of subtotal resection.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In addition, impaired quality of life was often reported in patients with residual hypoglycemia (9/29), which included persistent hypoglycemia requiring frequent snacks causing obesity or frequent hypoglycemic loss of consciousness.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Insulinoma: neurological impairment and cognitive function
“Even after undergoing these extensive treatments, neurological impairment still occurred in 22 (10.7%) patients with insulinoma: seven had dementia, seven had epilepsy and eight had other neurological deficits.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Eighteen out of thirty-four patients (53%) with insulinoma were screened positive for cognitive impairment as defined by a MoCA score <26.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The remaining ten patients with cognitive impairment showed improvements 1 year postoperatively, and seven patients recovered to normal cognitive function.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Malignant insulinoma: morbidity of refractory hypoglycemia
NICTH: long-term morbidity
No evidence found.